Abstract
Autoimmunity may evolve in predisposed individuals following an exogenous trigger. Autoimmunity is affected by genetic, immune, hormonal, and environmental factors. Immune mechanisms in heart diseases are complex and often not completely understood. Several cardiac disorders are believed to be mediated by an immune reaction. Both humoral and cellular immunity are associated with the development of myocarditis, dilated cardiomyopathy, heart failure, rheumatic fever, and atherosclerosis. Here the diagnostic criteria and autoimmune aspects of autoimmune-mediated cardiac disorders are reviewed. New diagnostic criteria for “autoimmune dilated cardiomyopathy” were recently suggested by the authors. They presume that establishing a dominant autoimmune etiology in some patients will have clinical significance because these patients will potentially gain the greatest benefit from immunosuppressive and immunomodulating treatments.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
(1992) Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 268: 2069-2073
(2004): Rheumatic fever and rheumatic heart disease: Report of a WHO expert consultation, Geneva, 29 October–November 2001 World Health Organ Tech Rep Ser, 923
Afanasyeva M, Georgakopoulos D, Rose NR (2004) Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun Rev 3: 476-486
Afek A, George J, Gilburd B et al (2000) Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun 14: 115-121
Aukrust P, Yndestad A, Ueland T et al (2006) The role of intravenous immunoglobulin in the treatment of chronic heart failure. Int J Cardiol 112: 40-55
Belizna CC, Richard V, Thuillez C et al (2007) Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev 7: 46-51
Caforio AL, Daliento L, Angelini A et al (2005) Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies. Lupus 14: 652-655
Caforio AL, Mahon NG, Baig MK et al (2007) Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 115: 76-83
Caforio AL, Vinci A, Iliceto S (2008) Anti-heart autoantibodies in familial dilated cardiomyopathy. Autoimmunity 41: 462-469
Carapetis JR, McDonald M, Wilson NJ (2005) Acute rheumatic fever. Lancet 366: 155-168
Celis R, Torre-Martinez G, Torre-Amione G (2008) Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?. Curr Opin Cardiol 23: 254-260
Cilliers AM (2006) Rheumatic fever and its management. BMJ 333: 1153-1156
de Leeuw K, Kallenberg C, Bijl M (2005) Accelerated atherosclerosis in patients with systemic autoimmune diseases. Ann N Y Acad Sci 1051: 362-371
Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564-1575
Desai A, Fang JC (2008) Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy. Heart Fail Clin 4: 87-97
Dorffel WV, Wallukat G, Baumann G et al (2000) Immunoadsorption in dilated cardiomyopathy. Ther Apher 4: 235-238
Elliott P (2000) Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy. Heart 84: 106-112
Eriksson U, Penninger JM (2005) Autoimmune heart failure: new understandings of pathogenesis. Int J Biochem Cell Biol 37: 27-32
Eriksson U, Ricci R, Hunziker L et al (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9: 1484-1490
Fae KC, Oshiro SE, Toubert A et al (2005) How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 24: 101-109
Felix SB, Staudt A (2008) Immunoadsorption as treatment option in dilated cardiomyopathy. Autoimmunity 41: 484-489
Frantz S, Bauersachs J, Kelly RA (2005) Innate immunity and the heart. Curr Pharm Des 11: 1279-1290
Fu M (2008) Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?. Autoimmunity 41: 415-418
George J, Harats D, Gilburd B et al (2000) Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102: 1822-1827
Gong KZ, Song G, Spiers JP et al (2007) Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches. Int J Clin Pract 61: 611-621
Guilherme L, Fae KC, Oshiro SE et al (2007) T cell response in rheumatic fever: crossreactivity between streptococcal M protein peptides and heart tissue proteins. Curr Protein Pept Sci 8: 39-44
Guilherme L, Kalil J (2004) Rheumatic fever: from sore throat to autoimmune heart lesions. Int Arch Allergy Immunol 134: 56-64
Guilherme L, Kalil J, Cunningham M (2006) Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39: 31-49
Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112: 7-14
Jahns R, Boivin V, Schwarzbach V et al (2008) Pathological autoantibodies in cardiomyopathy. Autoimmunity 41: 454-461
Jane-wit D, Tuohy VK (2006) Autoimmune cardiac-specific T cell responses in dilated cardiomyopathy. Int J Cardiol 112: 2-10
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348: 2007-2018
Kallwellis-Opara A, Dorner A, Poller WC et al (2007) Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 96: 469-480
Krebs P, Kurrer MO, Kremer M et al (2007) Molecular mapping of autoimmune B cell responses in experimental myocarditis. J Autoimmun 28: 224-233
Levin MJ, Hoebeke J (2008) Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas-heart disease. Autoimmunity 41: 429-433
Li HS, Ligons DL, Rose NR (2008) Genetic complexity of autoimmune myocarditis. Autoimmun Rev 7: 168-173
Li Y, Heuser JS, Cunningham LC et al (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177: 8234-8240
Liang CS, Mao W, Liu J (2008) Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway. Autoimmunity 41: 434-441
Limas CJ, Iakovis P, Anyfantakis A et al (2004) Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol 93: 1189-1191
Lindberg E, Magnusson Y, Karason K et al (2008) Lower levels of the host protective IL-10 in DCM — a feature of autoimmune pathogenesis?. Autoimmunity 41: 478-483
Mascaro-Blanco A, Alvarez K, Yu X et al (2008) Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity 41: 442-453
Matsuura E, Kobayashi K, Koike T et al (2002) Autoantibody-mediated atherosclerosis. Autoimmun Rev 1: 348-353
Mestroni L, Maisch B, McKenna WJ et al (1999) Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J 20: 93-102
Mobini R, Maschke H, Waagstein F (2004) New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev 3: 277-284
Muller II, Klingel K, Nikolaev VO et al (2008) Immunoadsorption in a 40 year old man with dilated cardiomyopathy and underlying active myocarditis. Clin Res Cardiol 97: 787-790
Nussinovitch U, Shoenfeld Y (2008) Intravenous immunoglobulin — indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7: 445-452
Nussinovitch U, Shoenfeld Y (2008) Autoimmune Dilated Cardiomyopathy. In: Shoenfeld Y, Cervera R, Gershwin M (eds) Diagnostic Criteria for the Autoimmune Diseases, 1st edn. The Humana Press Inc, New Jersey, USA
Piepoli MF (2007) Immune activation and inflammatory system in chronic heart failure: novel pathophysiological hypotheses generate new therapeutic options. Int J Clin Pract 61: 536-538
Quinn A, Kosanke S, Fischetti VA et al (2001) Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect Immun 69: 4072-4078
Rahamim-Cohen D, Shoenfeld Y (2001) The mosaic of autoimmunity. A classical case of inhalation of a polyclonal activating factor in a genetically and hormonally susceptible patient leading to multiple autoimmune diseases. Isr Med Assoc J 3: 381-382
Rakar S, Sinagra G, Di Lenarda A et al (1997) Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. Eur Heart J 18: 117-123
Rose NR (2008) Predictors of autoimmune disease: autoantibodies and beyond. Autoimmunity 41: 419-428
Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 14: 426-430
Saxena A (2000) Diagnosis of rheumatic fever: current status of Jones Criteria and role of echocardiography. Indian J Pediatr 67: 283-286
Sherer Y, Cerinic MM, Bartoli F et al (2007) Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 1108: 259-267
Sherer Y, Shoenfeld Y (2002) Immunomodulation for treatment and prevention of atherosclerosis. Autoimmun Rev 1: 21-27
Sherer Y, Shoenfeld Y (2008) Rheumatic Fever. In: Shoenfeld Y, Cervera R, Gershwin M (eds) Diagnostic Criteria for the Autoimmune Diseases, 1st edn. The Humana Press Inc, New Jersey, USA
Shoenfeld Y, Blank M, Abu-Shakra M et al (2008a) The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases — 2008. Isr Med Assoc J 10: 13-19
Shoenfeld Y, Gerli R, Doria A et al (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112: 3337-3347
Shoenfeld Y, Gilburd B, Abu-Shakra M et al (2008b) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases — 2008. Isr Med Assoc J 10: 3-10
Shoenfeld Y, Sherer Y, Harats D (2001) Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 22: 293-295
Shoenfeld Y, Zandman-Goddard G, Stojanovich L et al (2008c) The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases — 2008. Isr Med Assoc J 10: 8-12
Singh SK, Suresh MV, Voleti B et al (2008) The connection between C-reactive protein and atherosclerosis. Ann Med 40: 110-120
Szekanecz Z, Kerekes G, Der H et al (2007) Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci 1108: 349-358
Torre-Amione G (2005) Immune activation in chronic heart failure. Am J Cardiol 95:3C-40C; discussion 38C-40C
Usalan C, Buyukhatipoglu H, Tiryaki O (2007) Systemic lupus erythematosus complicated by dilated cardiomyopathy and severe heart failure. Clin Rheumatol 26: 125-127
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nussinovitch, U., Shoenfeld, Y. Autoimmunity and heart diseases: pathogenesis and diagnostic criteria. Arch. Immunol. Ther. Exp. 57, 95–104 (2009). https://doi.org/10.1007/s00005-009-0013-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-009-0013-1